An open-source repository-based tool for quality control of imaging protocol compliance: demonstration in a multicentre MRI study
Sam Keaveney(Royal Marsden NHS Foundation Trust), Christina Messiou(Institute of Cancer Research), Erica Scurr(Royal Marsden NHS Foundation Trust), Damien J. McHugh(University of Manchester), Matthew Blackledge(Institute of Cancer Research), Michael Berks(University of Manchester), Simon Doran(Institute of Cancer Research), Gordon Cook(University of Leeds), Dow‐Mu Koh(Royal Marsden NHS Foundation Trust), Winston J. Rennie(Leicester Royal Infirmary), Penny L. Hubbard Cristinacce(University of Manchester), Guy Pratt(University Hospitals Birmingham NHS Foundation Trust), Alina Dragan(Royal Marsden NHS Foundation Trust), Mauro Albrizio(Nottingham University Hospitals NHS Trust), Suchi Gaba(Royal Stoke University Hospital), Anjumara Nilak(Worcestershire Acute Hospitals NHS Trust), Jonathan R. Birchall(University of Cambridge), Paul Malcolm(Norfolk and Norwich University Hospital), Sarah Brown(University of Leeds), Martin Kaiser(Royal Marsden NHS Foundation Trust), Mihaela Rata(Royal Marsden Hospital), Andrew B. Gill, Sadie Roberts(University of Leeds), Andrew Hall(University of Leeds), Matthew Jenner(University Hospital Southampton NHS Foundation Trust), James P.B. O’Connor(Cancer Research UK), Alexander King(University Hospital Southampton NHS Foundation Trust), Sanjay Gandhi(Teva Pharmaceuticals (United States)), Amy Davis(Epsom and St Helier University Hospitals NHS Trust), Jessica Winfield(University Hospitals Birmingham NHS Foundation Trust), Priya Suresh(University Hospitals Plymouth NHS Trust), Aarti Abhishek Shah(Manipal Academy of Higher Education)
Cited by 2
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial
|The Lancet|2010|640
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
|The Lancet|2010|571
Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma
|Journal of Clinical Oncology|2015|564